/Matica Biotechnology and Texas A&M's NCTM Form Strategic Partnership to Deliver End-to-End Support for Cell and Gene Therapy Innovators

NEWS

Matica Biotechnology and Texas A&M's NCTM Form Strategic Partnership to Deliver End-to-End Support for Cell and Gene Therapy Innovators

PRNewswire

2025/05/05

Matica Biotechnology and Texas A&M's NCTM Form Strategic Partnership to Deliver End-to-End Support for Cell and Gene Therapy Innovators News provided by Matica Biotechnology, Inc. May 05, 2025, 08:00 ET Share this article Share to X Share this article Share to X Matica Biotechnology and NCTM logo

Summary

/PRNewswire/ -- Matica Biotechnology, a specialized contract development and manufacturing organization (CDMO) for cell and gene therapies (CGT), has entered...